H.-B. Bu et al. / Tetrahedron 67 (2011) 1114e1125
1123
H2/H6), 9.32 (d, J¼6.6 Hz, 2H, bipy-H20/H60), 8.86 (d, J¼6.6 Hz, 2H,
bipy-H3/H5), 8.74 (d, J¼6.3 Hz, 2H, bipy-H30/H50), 5.12 (t, J¼6.5 Hz,
2H, CH2eNþ), 4.72 (s, 3H, CH3eNþ), 3.18 (dt, J1¼6.4 Hz, J2¼2.5 Hz,
2H, CH2eC2), 2.68 (t, J¼2.5 Hz, 1H, C2H); 13C NMR (acetone-d6):
J1¼10 Hz, J2¼6 Hz, 1H, CH2eN), 4.54 (m, 1H, CHeO), 4.23 (dd,
J1¼11.9 Hz, J2¼2.3 Hz, 1H, CH2eOeTh), 4.22 (d, J¼12 Hz, 1H, man-
H6), 4.04 (br d, J¼12 Hz, 1H, man-H6), 4.00 (m, 1H, man-H5), 3.86/
3.84 (dd, J1¼11.9 Hz, J2¼6.2 Hz, 1H, CH2eOeTh), 2.08, 2.05, 1.97/
d¼151.49, 150.48, 147.78, 147.11, 127.96, 127.74, 78.97, 74.94, 61.00,
1.96, 1.91 (4s, 12H, CH3); 13C NMR (CDCl3):
d
¼170.70, 170.06, 169.91,
49.38, 21.54; elemental analysis: C15H16F12N2P2 (Mw 514.23), calcd
(%) C 35.04, H 3.14, N 5.45, found C 34.83, H 3.20, N 5.34.
169.73 (C]O), 151.65, 140.87, 140.09, 121.03, 100.84, 100.63, 97.00/
96.95, 71.82/71.81, 69.54, 69.05, 68.85, 66.19/66.17, 65.50, 62.46,
61.12/61.06, 50.08/50.06, 20.90, 20.72, 20.81, 20.70 (CH3); CI-MS:
m/e¼584 (HMþ, 100%); elemental analysis: C24H29N3O12S (Mw
583.57), calcd(%) C 49.40, H 5.01, N 7.20, S 5.49, found C 49.28, H
5.07, N 7.07, S 5.66.
4.3.5. Tetrathiafulvalene-4-carboxylic acid prop-2-ynylamide (3g). To
a stirred solution of tetrathiafulvalene-4-carbonylchloride (200 mg,
0.75 mmol) and propargylamine (184 mg, 3.35 mmol) in 15 ml of
anhydrous dichloromethane, was added triethylamine (1 ml, excess)
and stirring was continued at room temperature for 18 h. The solvent
was evaporated, and the residue was purified by flash
chromatography (silica gel, dichloromethane) to yield 122 mg (57%)
4.4.3. 2-{2-[1-(2,3-Dihydro-thieno[3,4-b][1,4]dioxin-2-ylmethyl)-1H-
[1,2,3]triazol-4-yl]-ethyl}-isoindole-1,3-dione (4c). According general
procedure, starting from 59.2 mg (0.3 mmol) 2, 59.7 mg (0.3 mmol)
of 3g as an orange solid.1H NMR (CDCl3):
d
¼7.15 (s,1H, Vinyl-H), 6.34
3c, 5.6 mg (15 mmol) Cu[CH3CN]4(PF6), and 19.1 mg (0.3 mmol)
(s, 2H, Vinyl-H), 5.72 (br s,1H, NH), 4.13 (dd, J1¼5.2 Hz, J2¼2.5 Hz, 2H,
Cu-powder in 1.2 ml acetonitrile. 4c was isolated as colorless solid in
87 mg (73%) yield by column chromatography (elution with
dichloromethane/ethyl acetate¼1:1 v/v). Mp 159 ꢂC.1H NMR (CDCl3):
CH2eN), 2.28 (t, J¼2.5 Hz, 1H, C2H); IR (KBr):
n
(cmꢀ1)¼3293, 3035,
2924, 2133, 1703, 1615, 1545, 1410, 1255, 948; EI-MS: m/e¼285 (Mþ,
100%); elemental analysis: C10H7NOS4 (Mw 285.41), calcd(%) C 42.08,
H 2.47, N 4.91, found C 41.91, H 2.39, N 4.80.
d
¼7.78 (m, 2H, Ph), 7.68 (m, 2H, Ph), 7.53 (s, 1H, triazole), 6.37 (d,
JAB¼3.7 Hz,1H, Th), 6.34 (d, JAB¼3.7 Hz,1H, Th), 4.62 (d, J¼5.4 Hz, 2H,
CH2etriazoleN), 4.51 (m, 1H, CHeO), 4.23 (dd, J1¼11.9 Hz, J2¼2.2 Hz,
1H, CH2eO), 4.02 (t, J¼7.0 Hz, 2H, CH2eimideN), 3.80 (dd, J1¼11.9 Hz,
J2¼6.5 Hz, 1H, CH2eO), 3.16 (t, J¼7.0 Hz, 2H, CH2etriazole); 13C NMR
4.4. General procedure for the synthesis of 1,2,3-triazolo-
functionalized EDOTs (4aed,feh)
(CDCl3):
d
¼168.1, 144.7, 140.9, 140.3, 133.95, 132.0, 123.2, 122.8,100.6,
Azidomethyl-EDOT 2, alkyne 3, and tetrakis(acetonitrile)copper
(I) hexafluorophosphate in a molar ratio of 1:1:0.05 (unless oth-
erwise stated) were dissolved in the given organic solvent. One
equivalent of copper powder was added and the mixture was
stirred for three days at room temperature. Subsequently, the
mixture was diluted with dichloromethane, chloroform or THF.
After separation of elemental copper by filtration, the solvent was
evaporated and the residue was purified by recrystallization or
column chromatography on silica gel.
100.4, 71.9, 65.4, 49.9, 37.5, 24.85; IR:
n
(cmꢀ1)¼3148, 3116, 2938,
2867,1770,1708,1484, 1188, 757, 723; CI-MS: m/e¼397 (HMþ, 100%);
elemental analysis: C19H16N4O4S (Mw 396.4), calcd(%) C 57.57, H 4.07,
N 14.13, found C 57.46, H 4.11, N 13.95.
4.4.4. 2-[2-(2,3-Dihydro-thieno[3,4-b][1,4]dioxin-2-ylmethyl)-1H-
[1,2,3]triazol-4-yl-ethyl]-7-octyl-benzo[lmn][3,8]phenanthroline-
1,3,6,8-tetraone (4d). According general procedure, starting from
72.4 mg (170 mmol) 3d, 63 mg (320 mmol) 2, 4 mg (11 mmol) Cu
[CH3CN]4(PF6), and 12.7 mg (0.2 mmol) Cu-powder in 0.5 ml THF. 4d
4.4.1. 4-Butyl-1-(2,3-dihydro-thieno[3,4-b][1,4]dioxin-2-ylmethyl)-
1H-[1,2,3]triazole (4a). According general procedure, starting from
592 mg (3 mmol) 2, 247 mg (3 mmol) hex-1-yne 3a, 56 mg
(0.15 mmol) Cu[CH3CN]4(PF6), and 191 mg (3 mmol) Cu-powder in
12 ml acetonitrile. 4a was isolated as colorless solid in 704 mg (84%)
yield by column chromatography (elution with dichloromethane/
ethyl acetate, stepwise increasing ethyl acetate up to 25 volume
was isolated as colorless solid in 96 mg (90%) yield, recrystallized
from benzeneeethanol (1:1). 1H NMR (CD2Cl2):
d¼8.65 (AB-system,
JAB¼7.5 Hz, 4H, naphth), 7.71 (br s, 1H, triazole), 6.33 (AB-system,
JAB¼3.6 Hz, 2H, Th), 4.64 (d, J¼4.7 Hz, 2H, CH2etriazoleN), 4.49 (m,
3H, CH2eimideN, CHeO), 4.23 (dd, J1¼11.8 Hz, J2¼1.6 Hz, 1H,
CH2eO), 4.15 (t, J¼7.6 Hz, 2H, CH2eimide), 3.75 (dd, J1¼11.8 Hz,
J2¼6.9 Hz, 1H, CH2eO), 3.20 (br s, 2H, CH2etriazole), 1.72 (ddt,
J¼7.5 Hz, 2H, CH2e),1.47 to 1.22 (m,10H, CH2e), 0.87 (t, J¼6.9 Hz, 3H,
percent). Mp 83 ꢂC. 1H NMR (CDCl3):
d
¼7.40 (s, 1H, triazole), 6.39
(AB-system, JAB¼3.7 Hz, 2H, Th), 4.63 (m, 2H, CH2eN), 4.56 (m, 1H,
CHeO), 4.27 (dd, J1¼11.9 Hz, J2¼2.1 Hz, 1H, CH2eO), 3.85 (dd,
CH3); 13C NMR (CD2Cl2):
d
¼163.21, 163.13 (C]O), 149.46, 141.45,
140.91, 131.16, 131.05, 127.22, 127.06, 126.74, 100.75, 100.57, 72.40,
65.97, 50.39, 41.24, 40.41, 32.23, 29.71, 29.62, 28.42, 27.52, 24.52,
J1¼11.9 Hz, J2¼6.2 Hz, 1H, CH2eO), 2.73 (t, J¼7.7 Hz, 2H,
a-CH2), 1.67
(m, 2H,
NMR (CDCl3):
49.7, 31.5, 25.3, 22.3, 13.8; IR (KBr):
b
-CH2), 1.39 (m, 2H,
g
-CH2), 0.94 (t, J¼7.3 Hz, 2H, CH3); 13
C
23.06, 14.26; IR:
n
(cmꢀ1)¼3114, 2955, 2925, 2854, 1707, 1663, 1485,
d
¼148.8, 140.8, 140.2,122.0, 100.46, 100.45, 71.9, 65.4,
1339, 1243, 1187, 1018, 769; CI-MS: m/e¼628 (HMþ, 100%); HRMS
n
(cmꢀ1)¼3111, 3065, 2958,
(ESI) calcd for C33H34N5O6S: 628.2224 (HMþ), found 628.2221.
2927, 2874, 1492, 1202, 1055, 1024, 777; EI-MS: m/e¼279 (Mþ,
100%); elemental analysis: C13H17N3O2S (Mw 279.3), calcd(%) C
55.89, H 6.13, N 15.04, found C 55.70, H 5.99, N 14.91.
4.4.5. N-{2-[1-(2,3-Dihydro-thieno[3,4-b][1,4]dioxin-2-ylmethyl)-
1H-[1,2,3]triazol-4-yl]-ethyl}-N0-methyl-4,40-bipyridinium bis(hexa-
fluorophosphate) (4f). According general procedure, starting from
4.4.2. 4-(2,3,4,6-Tetra-O-acetyl-
a
-
D
-mannopyranosyloxymethyl)-1-
59.2 mg (0.3 mmol) 2, 154.3 mg (0.3 mmol) 3f, 5.6 mg (15 mmol) Cu
(2,3-dihydro-thieno[3,4-b][1,4]dioxin-2-ylmethyl)-1H-[1,2,3]triazole
(4b). According general procedure, starting from 115.9 mg
(0.3 mmol) 3b, 59.2 mg (0.3 mmol) 2, 19.1 mg (0.3 mmol) Cu, and
5.6 mg (15 mmol) Cu[CH3CN]4(PF6), in 1.2 ml acetonitrile. 4b was
isolated as colorless, viscous oil in 143 mg (81%) yield by column
[CH3CN]4(PF6), and 19.1 mg (0.3 mmol) Cu-powder in 1.2 ml aceto-
nitrile. The crude product was dissolved in acetone (100 mg/ml) and
precipitated by addition of n-hexane. During magnetic stirring the
viscous oil crystallized yielding 4f as nearly colorless solid in 179 mg
(83%). Mp 180e190 ꢂC (decomposition). 1H NMR (acetone-d6):
chromatography (elution with dichloromethane/ethyl acetate¼1:1
d
¼9.37 (d, J¼6.6 Hz, 2H, bipy-H2/H6), 9.35 (d, J¼6.6 Hz, 2H, bipy-
v/v). 1H NMR (CDCl3):
d
¼7.66 (s, 1H, triazole), 6.37 (d, JAB¼3.7 Hz,
H20/H60), 8.77 (d, J¼6.3 Hz, 4H, bipy-H3/H5/H30/H50), 7.99 (s, 1H, tri-
azole), 6.47 (d, JAB¼3.6 Hz, 1H, Th), 6.43 (d, JAB¼3.6 Hz, 1H, Th), 5.32
(t, J¼6.5 Hz, 2H, CH2eNþ), 4.82 (dd, J1¼14.9 Hz, J2¼4.2 Hz, 1H,
CH2etriazoleN), 4.74 (dd, J1¼14.9 Hz, J2¼7.0 Hz, 1H, CH2etriazoleN),
4.74 (s, 3H, CH3eNþ), 4.61 (m, 1H, CHeO), 4.34 (dd, J1¼11.9 Hz,
J2¼2.2 Hz, 1H, CH2eO), 3.91 (dd, J1¼11.9 Hz, J2¼7.0 Hz, 1H, CH2eO),
1H, Th), 6.31 (d, JAB¼3.6 Hz, 1H, Th), 5.26 (dd, J1¼10.1 Hz, J2¼3.0 Hz,
1H, man-H3), 5.23 (t, J¼10.3 Hz, 1H, man-H4), 5.175 (dd, J1¼2.8 Hz,
J2¼1.4 Hz, 1H, man-H2), 4.90 (d, J¼1.7 Hz, 1H, man-H1), 4.80/4.79
(d, J¼12.4 Hz, 1H, CH2-triazole), 4.66/4.64 (d, J¼12.5 Hz, 1H, CH2-
triazole), 4.64 (dd, J1¼10 Hz, J2¼4 Hz, 1H, CH2eN), 4.62/4.61 (dd,